ABT
Abbott Laboratories
102.60$
+0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.2% | 14.5% | 15.4% | 20.3% | 20.6% | 19.2% | 22.8% | 24.5% | 21.9% | 18.1% | 20.4% | 21.6% | |
| 7.6% | 7.2% | 6.5% | 11.0% | 10.7% | 9.4% | 9.6% | 8.2% | 7.5% | 8.1% | 7.7% | 7.0% | |
| 1.2% | 1.4% | 1.5% | 1.5% | 1.6% | 1.6% | 1.6% | 1.5% | 1.6% | 1.6% | 1.6% | 1.5% | |
| 1.3% | -13.5% | 8.2% | -2.9% | 2.1% | 1.8% | 1.6% | 1.5% | 1.6% | – | – | – | |
| -2.4% | -0.8% | -7.3% | 7.0% | -0.5% | -4.2% | -2.6% | -1.8% | -3.5% | -6.2% | -22.0% | -1.8% | |
| 5.3% | 5.4% | 5.4% | 4.1% | 4.6% | 5.1% | 6.3% | 4.4% | 4.1% | 5.5% | 5.3% | 4.9% | |
| -1.0% | 2.0% | -1.2% | -35.1% | -4.4% | -5.7% | -6.4% | -4.7% | -4.0% | -7.8% | -5.6% | -5.5% | |
| 6.6% | 7.1% | 7.4% | 6.8% | 6.5% | 7.1% | 7.4% | 7.4% | 7.6% | 8.9% | 9.1% | 9.3% | |
| -10.8% | -11.0% | -2.5% | -3.0% | -0.8% | -2.3% | -1.2% | -5.3% | -8.7% | -3.1% | -3.1% | -2.0% | |
| 3.8% | 5.6% | 62.3% | -10.7% | -27.6% | -5.0% | -0.1% | -0.6% | 0.1% | -6.2% | -1.3% | -3.6% | |
| -13.5% | -11.0% | 53.5% | -19.3% | -34.0% | -13.4% | -8.0% | -12.8% | -17.5% | -17.7% | -12.9% | -14.2% | |
| 2.9% | 4.6% | 65.3% | -33.6% | -18.2% | 0.1% | 8.6% | 6.9% | 0.2% | -7.4% | 1.7% | 2.0% | |
| 12.8% | 9.1% | 10.0% | 16.2% | 16.0% | 14.1% | 16.5% | 20.1% | 17.9% | 12.6% | 15.1% | 16.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.